Victory Capital Management
AXDX icon

Victory Capital Management’s Accelerate Diagnostics AXDX Stock Holding History

Victory Capital Management’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-571
Closed -$48K – 2574
2020
Q1 		$48K Sell
571
-193
-25% -$27.2K ﹤0.01% 2530
2019
Q4 		$129K Buy
764
+176
+30% +$29K ﹤0.01% 2456
2019
Q3 		$109K Buy
+588
New +$114K ﹤0.01% 2408

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
Credit Suisse
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
ArrowMark Colorado Holdings
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Victory Capital Management's AXDX Position: Q2 2020 in Review

Victory Capital Management sold out of Accelerate Diagnostics (AXDX) in Q2 2020, closing a stake of 571 shares — an estimated $48K sold.

Victory Capital Management first reported a position in AXDX in Q3 2019 and held it in 3 quarters. The position peaked at $129K in Q4 2019. 123 funds tracked by Wall St. Rank hold AXDX as of Q2 2020.

  • Victory Capital Management reported no remaining Accelerate Diagnostics position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 571 Accelerate Diagnostics shares in Q2 2020, an estimated $48K.
  • Victory Capital Management first reported a position in Accelerate Diagnostics in Q3 2019 and held it in 3 quarters.
  • Victory Capital Management's Accelerate Diagnostics position peaked at $129K in Q4 2019.
  • 123 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.